InsiderTrades.com logo

PMCB Insider Trading

Insider Ownership Percentage: 10.33%
Insider Buying (Last 12 Months): $89,000.00
Insider Selling (Last 12 Months): $0.00

Nuvilex Insider Trading History Chart

This chart shows the insider buying and selling history at Nuvilex by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Nuvilex Share Price & Price History

Current Price: $0.88
Price Change: ▼ Price Decrease of -0.0394 (-4.28%)
As of 01/9/2026 05:00 PM ET

This chart shows the closing price history over time for PMCB up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Nuvilex Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/7/2026Jonathan SchechterDirectorBuy20,000$0.84$16,800.00192,500View SEC Filing Icon  
1/7/2026Joshua SilvermanCEOBuy40,000$0.83$33,200.00416,250View SEC Filing Icon  
1/5/2026Jonathan SchechterDirectorBuy20,000$0.78$15,600.00152,500View SEC Filing Icon  
1/5/2026Joshua SilvermanCEOBuy30,000$0.78$23,400.00346,250View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Nuvilex (NASDAQ:PMCB)

34.24% of Nuvilex stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PMCB by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Nuvilex Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2024Geode Capital Management LLC168,200$0.32M0.0%-4.8%2.190%Search for SEC Filing on Google Icon
11/15/2024K2 Principal Fund L.P.209,266$0.40M0.1%-36.1%2.725%Search for SEC Filing on Google Icon
5/14/2024K2 Principal Fund L.P.327,503$0.78M0.1%+7.5%3.876%Search for SEC Filing on Google Icon
2/14/2024K2 Principal Fund L.P.304,613$0.66M0.1%+17.8%3.534%Search for SEC Filing on Google Icon
11/15/2023Sabby Management LLC97,124$0.20M0.1%N/A1.106%Search for SEC Filing on Google Icon
11/13/2023K2 Principal Fund L.P.258,481$0.54M0.1%+67.6%2.944%Search for SEC Filing on Google Icon
10/17/2023Equitec Proprietary Markets LLC82,727$0.17M0.0%+34.7%0.942%Search for SEC Filing on Google Icon
8/15/2023K2 Principal Fund L.P.154,232$0.44M0.1%-78.7%1.757%Search for SEC Filing on Google Icon
8/14/2023CSS LLC IL13,186$38K0.0%N/A0.150%Search for SEC Filing on Google Icon
7/12/2023Equitec Proprietary Markets LLC61,415$0.18M0.1%-81.4%0.366%Search for SEC Filing on Google Icon
5/11/2023K2 Principal Fund L.P.723,271$2.06M0.3%-1.2%4.146%Search for SEC Filing on Google Icon
2/10/2023K2 Principal Fund L.P.732,105$2.15M0.3%+19.8%3.909%Search for SEC Filing on Google Icon
1/10/2023FNY Investment Advisers LLC31,100$90K0.1%N/A0.166%Search for SEC Filing on Google Icon
10/26/2022IQ EQ FUND MANAGEMENT IRELAND Ltd38,771$93K0.0%N/A0.187%Search for SEC Filing on Google Icon
10/11/2022Equitec Proprietary Markets LLC330,694$0.79M0.2%-3.6%1.594%Search for SEC Filing on Google Icon
10/4/2022Csenge Advisory Group200,104$0.48M0.0%N/A0.964%Search for SEC Filing on Google Icon
7/18/2022Equitec Proprietary Markets LLC342,994$0.77M0.2%+10.9%1.655%Search for SEC Filing on Google Icon
5/17/2022Shay Capital LLC944,666$2.17M0.3%+42.6%4.559%Search for SEC Filing on Google Icon
4/25/2022FNY Investment Advisers LLC59,066$0.14M0.1%N/A0.285%Search for SEC Filing on Google Icon
4/22/2022Equitec Proprietary Markets LLC309,294$0.71M0.2%+19.6%1.493%Search for SEC Filing on Google Icon
2/15/2022Shay Capital LLC662,337$1.66M0.3%+4,434.7%3.197%Search for SEC Filing on Google Icon
1/31/2022Equitec Proprietary Markets LLC258,694$0.65M0.1%N/A1.249%Search for SEC Filing on Google Icon
11/16/2021Schonfeld Strategic Advisors LLC88,200$0.28M0.0%N/A0.426%Search for SEC Filing on Google Icon
11/12/2021NorthRock Partners LLC37,164$0.12M0.0%N/A0.179%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Nuvilex logo
PharmaCyte Biotech, Inc., a biotechnology company, develops and commercializes cellular therapies for cancer in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. The company develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; and license agreements with SG Austria Pte. Ltd. and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.
Read More on Nuvilex

Today's Range

Now: $0.88
Low: $0.87
High: $0.94

50 Day Range

MA: $0.84
Low: $0.63
High: $1.22

52 Week Range

Now: $0.88
Low: $0.63
High: $1.90

Volume

204,151 shs

Average Volume

457,527 shs

Market Capitalization

$8.93 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.04

Who are the company insiders with the largest holdings of Nuvilex?

Nuvilex's top insider investors include:
  1. Joshua Silverman (CEO)
  2. Jonathan Schechter (Director)
Learn More about top insider investors at Nuvilex.